Market Overview - The Shanghai Composite Index increased by 0.24% as of the morning close, with a trading volume of 677.93 million shares and a total transaction value of 1,159.189 billion yuan, representing a decrease of 7.38% compared to the previous trading day [1] Industry Performance - The top-performing industries included: - Defense and Military Industry: Increased by 2.39%, with a transaction value of 800.46 billion yuan, led by Xin Jing Gang, which rose by 20.02% [1] - Environmental Protection: Increased by 1.35%, with a transaction value of 99.35 billion yuan, led by Zhenghe Ecology, which rose by 10.02% [1] - Machinery Equipment: Increased by 1.18%, with a transaction value of 890.59 billion yuan, led by *ST Xin Yan, which rose by 17.71% [1] - The worst-performing industries included: - Coal: Decreased by 1.36%, with a transaction value of 47.63 billion yuan, led by Yun Wei Shares, which fell by 3.10% [2] - Agriculture, Forestry, Animal Husbandry, and Fishery: Decreased by 0.87%, with a transaction value of 177.67 billion yuan, led by Biological Shares, which fell by 5.92% [2] - Media: Decreased by 0.40%, with a transaction value of 190.78 billion yuan, led by Kaiying Network, which fell by 4.27% [2]

Market Overview - Victory Energy (001331) has achieved an 8-day consecutive limit-up, while Luyuan Pharmaceutical (002788) has seen a 5-day consecutive limit-up. Other notable stocks include Jiamei Packaging (002969) with 6 limit-ups in 8 days and Shenjian Co. (002361) with 4 consecutive limit-ups [1] - The market experienced a pullback after a rise, with the ChiNext Index rising over 1% during the day. The total trading volume in the Shanghai and Shenzhen markets reached 1.9 trillion yuan, an increase of 37.9 billion yuan compared to the previous trading day [1] - Nearly 3,900 stocks in the market declined, while sectors such as photolithography machines, batteries, and the Hainan Free Trade Zone saw significant gains [1] Industry Highlights - The lithium battery sector was boosted by a renewed price surge in the supply chain, with companies like Tianji Shares (002759) and Duofluoride (002407) hitting the daily limit. Lithium mining stocks such as Dazhong Mining (001203) and Tianhua New Energy (300390) saw increases of over 10% [1] Company News - Ningbo Huaxiang (002048) announced that its subsidiary, Huaxiang Qiyuan, signed a contract to produce robot joints for a leading domestic manufacturer, which is expected to enhance its competitive advantage in the smart robot components market [2] - Victory Energy (001331) clarified that it does not engage in robot-related business and has no plans for asset restructuring in the next 12 months. The company has seen a cumulative stock increase of 114.44% over the past 8 trading days [2] - *ST Xinyan (300159) will resume trading on December 24, 2025, after completing a capital increase plan that will raise its total share capital from 1.496 billion shares to 3.29 billion shares through a 10-for-12 bonus share issuance [3]

Major Announcements - Victory Energy has clarified that it does not engage in robotics-related business and has no asset restructuring plans for the next twelve months, despite its stock experiencing an 8-day trading limit increase of 114.44% since December 12 [1] - Aerospace Engineering confirmed that its main business does not involve commercial aerospace, with a current rolling P/E ratio of 76.85, significantly higher than the industry average [2] - ST Songfa's subsidiary, Hengli Shipbuilding, signed contracts for the construction of 8 vessels, with a total contract value estimated between 500 million to 800 million USD [3] - Libet has stated it does not engage in controllable nuclear fusion business, with its nuclear power-related contracts amounting to 226 million CNY, representing 6.48% of its audited revenue for 2024 [4] - Zhuhai Mian Group has completed the 100% equity transfer of Gree Real Estate for a transaction price of 5.518 billion CNY [5] Investments and Projects - Ningbo Huaxiang's subsidiary has signed a contract for the production of robot joints, which is expected to positively impact future performance starting January 2026 [6][7] - Haibo Shichuang plans to invest 2 billion CNY to build a smart green energy storage factory, expected to be completed by December 2028 [8] - Zhenyu Technology's subsidiaries plan to invest at least 1 billion CNY each in projects related to humanoid robots and core components for electric vehicle drive systems [10] Corporate Actions - ST Lian Stone has completed its restructuring plan and will have its delisting risk warning lifted on December 25, 2025 [9] - Huaxin Building Materials' major shareholder plans to increase its stake by 200 million to 400 million CNY [11] - Nova Star Cloud has secured a loan commitment of up to 135 million CNY for share repurchase [13] - Fanwei Network intends to repurchase and cancel 4.2371 million shares, representing 1.63% of its total share capital [14] - Dong'a Ejiao has conducted its first share repurchase, totaling approximately 19.9976 million CNY [15] Stock Trading and Resumption - ST Xinyan's stock will resume trading on December 24, 2025, following a capital increase from 1.496 billion shares to 3.29 billion shares [16]

Core Viewpoint - The company *ST Xinyan announced that its stock will resume trading on December 24, 2025, following a restructuring plan that involves a significant increase in its total share capital through a capital reserve conversion [1] Group 1: Capital Increase - The company will implement a capital reserve conversion at a ratio of 12 new shares for every 10 existing shares, resulting in a total increase of 1.795 billion shares [1] - The total share capital will rise from 1.496 billion shares to 3.29 billion shares after the conversion [1] - Out of the newly issued shares, 1.435 billion will be subject to lock-up restrictions post-initial public offering, while 360 million shares will be freely tradable [1]

格隆汇12月23日丨*ST新研(300159.SZ)公布，根据《新疆机械研究院股份有限公司重整计划》，公司以 现有总股本1,495,645,923股为基数，按每10股转增12股的比例实施资本公积转增股本，共计转增产生 1,794,775,108股。本次转增的股份中，1,434,774,108股为首发后限售股，360,000,000股为无限售条件流 通股。截至本公告日，公司已经完成转增，公司总股本由1,495,645,923股增加至3,290,421,031股。股票 将于2025年12月24日开市起复牌。 ...

Group 1 - Shareholder of Okoyi plans to reduce holdings by up to 1.89% of the company's shares, amounting to a maximum of 3 million shares due to personal funding needs [1] - Tianchuang Fashion is planning a change in control, leading to continued suspension of its stock trading, expected to last no more than 3 trading days [2] - China Electric Power Construction Company reported a new contract amount of 10,317.55 billion yuan for the first 11 months of 2025, a year-on-year decrease of 1.65% [3] Group 2 - Pilin Bio's wholly-owned subsidiary received approval for a clinical trial of a drug, indicating progress in its product development [4] - Yihong Medical obtained two medical device registration certificates for diagnostic kits, enhancing its product portfolio [5] - Aohong Electronics plans to use up to 450 million yuan of idle fundraising for cash management, targeting safe and liquid financial products [6] Group 3 - China Electric Power Construction signed a contract worth approximately 6.626 billion yuan for a natural gas booster station project in Turkey, with a construction period of about 55 months [7] - Baosheng Co. won a bid for a power cable project in Singapore, valued at around 1.2 billion yuan, marking the largest overseas order in its history [8] - *ST Xinyan's stock will resume trading on December 24, 2025, following a capital increase plan that will raise its total share capital to 3.29 billion shares [9] Group 4 - Ningbo Construction's subsidiary signed a construction contract worth 428 million yuan for an engineering project with a duration of 990 days [11] - Lianhuan Pharmaceutical's subsidiary received approval for a drug that passed the consistency evaluation for generic drugs, enhancing its market competitiveness [12] - Zhongjie Automotive received a project designation for a new electric air conditioning compressor, with expected sales of approximately 29.86 million USD over its lifecycle [13] Group 5 - Biopharmaceuticals' major shareholder plans to increase holdings by 50 million to 100 million yuan, indicating confidence in the company's future [14] - Haizheng Pharmaceutical's subsidiary received approval for a veterinary drug product, expanding its product offerings in the animal health sector [15] - *ST Songfa's subsidiary signed contracts for the construction of 8 vessels, with a total contract value between 200 million to 400 million USD [16] Group 6 - Shandong Pharmaceutical Glass announced the resignation of its chairman due to age reasons, indicating a potential leadership transition [17] - Xinno Wei's subsidiary received approval for a clinical trial of a monoclonal antibody drug, indicating advancements in its drug development pipeline [18] - Ningbo Huaxiang's subsidiary secured an order for robot joints, expected to positively impact future business performance [19][20] Group 7 - China Resources Double Crane's subsidiary received approval for a clinical trial of a drug aimed at treating a genetic eye disease, reflecting ongoing R&D efforts [21] - Huaxin Technology's shareholders set a transfer price of 56.69 yuan per share for a block of shares, indicating active shareholder engagement [22] - Xinhua Net announced the resignation of its president due to job relocation, suggesting potential changes in management [23] Group 8 - Taiji Group plans to transfer a 40% stake in a subsidiary to focus on its core pharmaceutical business, enhancing operational efficiency [24] - Huaxin Construction's shareholder plans to increase holdings by 200 million to 400 million yuan, reflecting confidence in the company's prospects [25] - Dongjie Intelligent is planning to issue shares and cash for asset acquisition, with stock trading suspended until further notice [26] Group 9 - Wanrun New Energy was designated as a delivery warehouse for lithium carbonate futures, indicating its strategic position in the market [27] - Prolo Pharmaceutical's subsidiary received a drug registration certificate for an influenza treatment, expanding its product range [28] - Saiwu Technology invested 5 million yuan in a private equity fund focused on smart vehicles and energy innovation, indicating strategic investment in growth sectors [29] Group 10 - Bohui Innovation's subsidiary received approval for a clinical trial of an immunoglobulin drug, indicating progress in its product development [30] - Bohui Innovation's subsidiary also received a drug registration certificate for a coagulation factor product, enhancing its therapeutic offerings [31] - Hanghua Co. plans to allocate 146 million yuan of surplus fundraising for a new green printing materials project, reflecting a commitment to sustainability [32] Group 11 - Nova Star Cloud obtained a loan commitment letter from a bank for a share repurchase plan, indicating financial support for its capital management strategy [33] - Jimin Health established a joint venture for technology innovation, indicating a strategic move to enhance its technological capabilities [34] - Huili Pharmaceutical received a drug registration certificate for a medication used in treating digestive ulcers, expanding its product portfolio [35]

Group 1 - The company *ST Xin Yan will resume trading on December 24, 2025, after a capital reserve increase in share capital, with a reference opening price adjusted to 2.88 yuan per share [1] - The capital reserve increase will result in a total share capital increase from 1,495,645,923 shares to 3,290,421,031 shares, with a ratio of 12 shares for every 10 shares held [1] - The company has completed the share increase, with 1,434,774,108 shares being restricted and 360,000,000 shares being freely tradable [1] Group 2 - For the first half of 2025, the company's revenue composition shows that specialized equipment manufacturing for agricultural and by-product processing machinery accounts for 75.11%, while aerospace component manufacturing accounts for 24.89% [2] - The current market capitalization of *ST Xin Yan is 5.1 billion yuan [3]

证券代码：300159 证券简称：*ST 新研 公告编号：2025-078 新疆机械研究院股份有限公司 关于重整计划资本公积金转增股本实施进展暨公司股票复牌的 公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、新疆机械研究院股份有限公司（以下简称"公司"）股票将于 2025 年 12 月 24 日开市起复牌。 2、鉴于本次资本公积金转增股本股权登记日当日（2025 年 12 月 23 日） 公司股票停牌，股权登记日公司股票收盘价为股权登记日前一交易日（2025 年 12 月 22 日）公司股票收盘价，即 3.39 元/股，高于本次重整资本公积金转增股 本的平均价 2.45 元/股。故公司股权登记日次一交易日（2025 年 12 月 24 日） 的股票开盘参考价应当依据公司本次调整后的除权参考价格的计算公式进行除 权调整，调整为 2.88 元/股。 3、根据《新疆机械研究院股份有限公司重整计划》（以下简称"重整计划"）， 公司以现有总股本 1,495,645,923 股为基数，按每 10 股转增 12 股的比例实施 资本公积转增股本，共计转增 ...

证券代码：300159 证券简称：*ST 新研 公告编号：2025-079 新疆机械研究院股份有限公司 关于资本公积金转增股本实施后首个交易日开盘参考价调 整事项的风险提示公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假 记载、误导性陈述或重大遗漏。 特别提示： 新疆机械研究院股份有限公司（以下简称"公司"或"新研股份"）于 2025 年 12 月 18 日于巨潮资讯网披露了《关于重整计划资本公积金转增股本事项实施 的公告》（公告编号：2025-073）。本次重整公司资本公积金转增股本的平均价 格为 2.45 元/股。鉴于本次资本公积金转增股本股权登记日当日（2025 年 12 月 23 日）公司股票停牌，股权登记日公司股票收盘价为股权登记日前一交易日 （2025 年 12 月 22 日）公司股票收盘价，即 3.39 元/股，高于本次重整资本公积 金转增股本的平均价 2.45 元/股。故公司股权登记日次一交易日（2025 年 12 月 24 日）的股票开盘参考价应当依据公司本次调整后的除权参考价格的计算公式 进行除权调整，调整为 2.88 元/股。 2025 年 12 月 16 日， ...

申万宏源证券承销保荐有限责任公司 关于新疆机械研究院股份有限公司调整资本公积 转增股本除权参考价格的计算结果的专项意见 一、重整过程 2025 年 5 月 30 日，中国信达资产管理股份有限公司四川省分公司（以下简 称"信达资产"）以新疆机械研究院股份有限公司（以下简称"公司"或"新 研股份"）不能清偿到期债务且资产不足以清偿全部债务，但具有重整价值为 由，向乌鲁木齐市中级人民法院（以下简称"乌鲁木齐中院"）提交了对公司 的重整及预重整申请。2025 年 11 月 14 日，信达资产以新研股份子公司四川新 航钛科技有限公司（以下简称"四川新航钛"或"子公司"）不能清偿到期债 务且资产不足以清偿全部债务，但具有重整价值为由，向乌鲁木齐中院申请对 子公司进行重整，同时申请四川新航钛与新研股份协同重整并实施集中管辖。 2025 年 8 月 28 日，公司披露了《新疆机械研究院股份有限公司关于与重整 产业投资人签署〈重整投资协议〉的公告》（公告编号：2025-057），2025 年 11 月 13 日，公司披露了《新疆机械研究院股份有限公司关于与重整财务投资 人签署重整投资协议的公告》（公告编号：2025-063）。 ...